Search

everythinglearnresearchcommunity

for

Search:↓

Tea extracts can protect hair from UV damage.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Teak leaf extract hair tonic was tested for hair growth and safety.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Human thymus has stem cells that can self-renew and maintain their identity.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Green tea leaf extract at 7.5% concentration effectively promotes hair growth, similar to minoxidil.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

The boy's genetic diagnosis of ectodermal dysplasia helped improve management and counseling for him and his sister.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.

Tofacitinib might be used to treat hair loss.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

SeV-Tp speeds up healing of drug-resistant infections by targeting wounds and killing bacteria with light activation.

The FDA rejected a testosterone drug again due to safety concerns.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Direct-to-consumer teledermatology is growing fast but raises concerns about quality of care and doctor-patient relationships.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.